Medical Breakthrough in the Philippines in Curing Hepatitis B by Chelation Therapy
Dr. Arturo V. Estuita, MD, Internist and chelationist. He was a guest on a TV program in Japan
Dr. Estuita, MD interviewed at CSR TV Japan by Larry D. Brouhard
Small needle inserted in an artery thru which chelation solution gets into the body
A control of hepatitis B is now at hand
I can’t hold it anymore: this jubilation from learning that the conquest of Hepatitis B is now at hand!
I don’t intend to grab the glory due Dr. Arturo V. Estuita, MD, a Filipino internist and chelationist, who has come up with the clinical proof that the virus causing Hepatitis B can be controlled in the afflicted patient.
Take note, in a live person afflicted with Hepatitis B; not in the test tube or experimental mice.
In his chelation clinic at Pasay City, Philippines, Dr. Estuita showed me on March 8,2012 the raw data. From millions of virus in a Hepatitis B patient the population of virus was reduced to only thousands after treatment with infusion chelation therapy.
I will not show here the exact figures. Dr. Estuita intends to write and publish his findings in a medical journal soon. Let him hug the limelight.
New entries as of July 5,2012.
His first patient on the chelation of Hepatitis B virus has already been employed as a crew in a commercial ocean-going ship. That means the fellow had a test on Hepatitis B conducted by an accredited clinic of the shipping company and it was found out that he was clear of Hepatitis B virus, according to Dr. Estuita. This fellow was positive for Hepatitis B when Dr. Estuita started the infusion chelation therapy. His virus load was counted at 8 million. After 8 to 10 sessions of chelation therapy, his virus load went down dramatically to 425,000. After 35 sessions his virus load was down to less than 10,000. At this virus load, he was pronounced as cured and can no longer infect another person. A test conducted by the accredited clinic of the shipping company agreed with the certification issued by Dr. Estuita that he is cured and no longer communicable. There are now more patients coming to Dr. Estuita for the elimination of Hepatitis B virus, Dr. Estuita told me in a phone interview. A new gadget that has just hit the market makes the counting of virus load easier which gives the result of the test much faster, four to five days. End of new entries.
What is the significance of Dr. Estuita’s discovery?
Hepatitis is a disease of the liver caused by a variety of virus.
“Hepatitis A is caused by the hepatitis A virus, hepatitis B is caused by the hepatitis B virus, and hepatitis C by the hepatitis C virus…
“The patient may have a number of symptoms, including fatigue, loss of appetite, abdominal discomfort, jaundice (yellow color of the eyes or skin), and other abnormal liver blood tests” (Abou-Alfa, G. K, MD. and R. P. DeMatteo, MD. 100 Questions & Answers About Liver Cancer. 2009. 2nd edition:10)
The body eliminates hepatitis A virus after an inflection with it and the person’s risk for cirrhosis or liver cancer does not increase. However, persons infected with hepatitis B and C virus never completely get rid of the virus and they are at risk for developing cirrhosis and liver cancer.(Abou-Alfa and DeMatteo's book does not include hepatitis D.)
In cirrhosis, liver tissues are replaced with scarred hard tissues. Cirrhosis is a kind of embalming while the person is still alive (Cranton, E. MD and A. Brecher. Bypassing Bypass. 1984:205).
So far, the world of medicine knows that only the virus causing hepatitis A could be eliminated by the body. Now Dr. Estuita, MD has discovered that infusion chelation therapy kills hepatitis B virus while it is in the body of a person. It is probable that infusion chelation therapy can also kill hepatitis C and D virus, says Dr. Estuita. That is interesting to find out, according to him. He will have that opportunity when patients afflicted with these virus come to him for treatment. ('virus' is being used in the singular and plural forms.)
Vaccine is a means to prevent infection with a virus. The first such vaccine was invented by Dr. Thomas Francis, Jr. and Dr. Jonas Salk against N1H1 or the Spanish flu pandemic that killed 25 million people around the world in 1918, including 44,000 American soldiers deployed in the European theater in World War 1. The N1H1 vaccine was given to American soldiers deployed in the same theater in WWII against Hitler’s army.
Then the Salk killed-polio vaccine that Dr. Jonas Salk and his team invented was launched in1955 against the polio bug.
Next came the live attenuated polio vaccine invented by Dr. Albert Sabin in 1959 known as the oral polio vaccine. In the USA only the Salk vaccine is being administered since 2000.
Cirrhosis has causes other than hepatitis virus, like alcohol. Liver cancer is caused by free radicals and reactive oxygen species that act like free radicals. This is discussed in my other Hub "Hepatitis B Puts You At Risk To Get Sick of Cancer and Cirrhosis."
How hepatitis B and C can lead to cancer
Hepatitis B virus can be transmitted by sexual contact, blood transfusion, body fluid, recycled syringe used on infected person, manicure and pedicure when the tools had been used on infected person, tattoo, blood of an infected mother during giving birth.
The first dose of hepa B vaccine should be administered after birth or within 2 months. The second dose should be given in one to 2 months after the first dose; the third dose between 6 months and 18 months of age.
"If you have chronic viral infection, then you are at risk for developing cirrhosis and/or liver cancer....
"The goal of the treatment is to reduce the amount of virus in your body and thus lower the risk of getting cirrhosis or cancer...." (Abou-Alfa, G. K, MD. and R. P. DeMatteo, MD. page 11).
Before 1992 when screening for hepatitis C was not yet around, people who got blood transfusion may have got this virus. It's rare now to transmit it through blood transfusion. However, hepatitis C can be transmitted by intravenous drug users, health care givers, or people having tattoos. If you have an infection you have a 20% risk for developing cirrhosis and 5% risk for developing liver cancer, wrote Abou-Alfa and DeMatteo. The goal of treatment is to reduce these risks. The body cannot completely eliminate hepatitis B and C.
Hepatitis B and C cause cirrhosis then liver cancer. However, some people may have cirrhosis but not liver cancer, wrote Abou-Alfa and DeMatteo.
Infected persons should be treated to prevent the contamination of other persons who come into contact with them.
In fact, virus do not cause cancer; they only trigger it, as follows:
The macrophages, components of the immune system, shoot the infected cells and virus with free radicals used like bullets (Cranton, E. MD and A. Brecher. Bypassing Bypass. 1984). The macrophages use nitric oxide, a gas free radical, produced by the enzyme inducible nitric oxide synthase (iNOS). iNOS/NO kills the virus and induces inflammation in infected cells and healthy cells in the vicinity. iNOS/NO inflict damage on the DNA of hitherto healthy cells in the vicinity of infected cells resulting in mutation, in turn, resulting in tumor. A tumor that metastasize (break out of its confinement and spread) graduates into cancer. Tumor or cancer starts with one mitotic cell only.
Let's digress a little bit. Mitotic means dividing cell of the sibling or a person having 46 chromosomes in the nucleus, not in cells undergoing meiosis with 23 chromosomes. A mitotic cell actually has 37 chromosomes in its mitochondria and 46 chromosomes in its nucleus. Cell division is the means of growth; a cancer cell goes into cell division that is uncontrollable.
Editing as of March 11,2013
Another way cancer can develop is by copying error. Damaged liver cells attempt to repair themselves. This repair job involves copying of DNA and RNA. Sometimes copying error occurs. A wrong information code or a wrong message can result in tumor then cancer. End of editing.
Those who doubt the efficacy of infusion chelation therapy should search Internet with cv chelation therapy cranton frackelton and read an updated article of Dr. Elmer M. Cranton, MD and Dr. James P. Frackelton, MD entitled "Current Status of EDTA Chelation Therapy in Occlusive Arterial Disease."
Vaccine against hepatitis B cannot give a complete protection. That infusion chelation therapy can kill hepatitis B virus in the patient will eventually clear afflicted persons of hepatitis B virus. Hopefully, of hepatitis C and D virus as well.
New entries as of September 22,2012
Dr. Estuita told me today that he has already treated 10 victims of hepatitis B virus. These cases were authenticated as shown by the virus count obtained by means of a gadget that gives a virus count readout. This gadget is new. End of new entries.
New entries as of October 25,2012
What follows is a message for Dr. Estuita who forwarded it to me. I am taking the liberty inasmuch as it pertains to "mankind" to post it (with light editing) here:
Hello, Dr. Estuita, I am Dr. Patrick Adrani, a general practitioner from Uganda (East Africa), I am impressed by your cv chelation therapy in the treatment/cure of hepatitis. I would like to congratulate you for this great scientific innovation towards mankind. However, I would like to know how much it costs in terms of dollars and treatment duration for a full course of treatment especially for our poor patients from Africa. Thanks in advance. God bless you.
I have just posted a new Hub "http://conradofontanilla.hubpages.com/hub/Hepatitis-B-Puts-You-AT-Risk-Of-Getting-Sick-Of-Liver-Cancer-And-Cirrhosis.
New entries as of April 22.2014
Indicators of hepatitis B for treatment
A study conducted by Taiwan for 15 years has established accurate indicators for the need of treatment for hepatitis B (Steven-Huv Han. Hepatitis B - Treatment and Consequences. Youtube. Internet. April 20.2014). These indicators are viral load and ALT (alanine amino transferase). The threshold levels are: viral load less than 20,000 international units/ml and ALT less than 1 x ILN. At these levels just monitor the disease; no treatment is needed.
ALT is enzyme that killed cells release owing to the struggling between the virus and T-Killers cells, a component of the immune system. ALT is like the enzyme released by killed heart muscles owing to heart attack. This enzyme is MB fraction creatine kinase or CK-MB. High amount of CK-MB persists in the blood even when heart attack had occurred one week earlier. So a person who suffered a heart attack can be diagnosed despite the fact that he was not immobilized or paralyzed by the attack.
At 20,000 IU/ml level of viral load, the virus do not replicate and the person is no longer communicable. Blood test shows only that surface protein that are not infectious exist in the body. Dr. Estuita is more cautious that is why he reduces viral load down to 10,000 IU/ml then stops treatment.
High amount of ALT persists especially during the acute stage of hepatitis B, three to four months after the infection.
I have a new Hub, "Accurate Indicators to go for Hepatitis B treatment."
Hepatitis B virus has developed resistance to drugs like interferon, lamivudine, fevoir and more, according to Dr. Steven-Huv Han.
Chelation safe and effective for heart disease and diabetes
USA Institutes of Health (National Institute of Heart, Lung and Blood) launched in 2002 a study called "Trials to Assess Chelation Therapy" (TACT. This is a double blind randomized with control study that has showed that chelation therapy is safe and effective for heart disease. TACT also found that chelation therapy is safe and effective for diabetes.
Results of the study were presented at a meeting of the American Heart Association held in Los Angeles, California on November 4,2012. The study costs $30 million. So, that chelation is safe and effective is proven by double blind study, not just by anecdotes.
In 2012, Dr. Estuita discovered that chelation therapy is also safe and effective for the treatment of hepatitis B. He has already treated 20 hepatitis B patients.
Hubs related to hepatitis B written by conradofontanilla